Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Research & Development (2022 - 2025)

Historic Research & Development for Cannabis Bioscience International Holdings (CBIH) over the last 4 years, with Q3 2025 value amounting to $213.0.

  • Cannabis Bioscience International Holdings' Research & Development rose 5000.0% to $213.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $588.0, marking a year-over-year decrease of 3488.37%. This contributed to the annual value of $517.0 for FY2025, which is 7496.37% down from last year.
  • According to the latest figures from Q3 2025, Cannabis Bioscience International Holdings' Research & Development is $213.0, which was up 5000.0% from $63.0 recorded in Q2 2025.
  • Over the past 5 years, Cannabis Bioscience International Holdings' Research & Development peaked at $1772.0 during Q1 2023, and registered a low of $63.0 during Q2 2025.
  • In the last 4 years, Cannabis Bioscience International Holdings' Research & Development had a median value of $214.0 in 2025 and averaged $684.83.
  • As far as peak fluctuations go, Cannabis Bioscience International Holdings' Research & Development tumbled by 9165.2% in 2024, and later skyrocketed by 5000.0% in 2025.
  • Quarter analysis of 4 years shows Cannabis Bioscience International Holdings' Research & Development stood at $1548.0 in 2022, then crashed by 87.27% to $197.0 in 2023, then crashed by 50.76% to $97.0 in 2024, then surged by 119.59% to $213.0 in 2025.
  • Its Research & Development was $213.0 in Q3 2025, compared to $63.0 in Q2 2025 and $215.0 in Q1 2025.